Location History:
- Laval, CA (2013)
- Burlington, CA (2017)
Company Filing History:
Years Active: 2013-2017
Title: Araz Jakalian: Innovator in Viral Inhibition
Introduction
Araz Jakalian is a notable inventor based in Burlington, California. He has made significant contributions to the field of virology, particularly in the development of inhibitors for viral replication. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Jakalian's latest patents include innovative compounds aimed at combating viral infections. One of his patents focuses on respiratory syncytial virus (RSV) inhibitors, specifically compounds of Formula (I), wherein R, R, R, and n are defined, which are useful as inhibitors of RSV. Another significant patent addresses inhibitors of human immunodeficiency virus (HIV) replication, detailing compounds of formula (I) where c, X, Y, R, and R are defined, which are effective in inhibiting HIV replication.
Career Highlights
Throughout his career, Araz Jakalian has worked with prominent companies in the pharmaceutical industry. He has been associated with Gilead Sciences, Inc. and Medivir AB, where he has contributed to research and development efforts aimed at creating effective antiviral therapies.
Collaborations
Jakalian has collaborated with esteemed professionals in his field, including Christian Brochu and Youla S. Tsantrizos. These collaborations have likely enhanced the quality and impact of his research.
Conclusion
Araz Jakalian's innovative work in developing viral inhibitors showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral infections, and his patents reflect his expertise and dedication to improving public health.